COMPLETE GENOMICS
LIVE

Serial Number

98032973

Owner

Complete Genomics, Inc.

Attorney

R. Gwen Peterson

Filing Date

Jun 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

COMPLETE GENOMICS Trademark

Serial Number: 98032973

COMPLETE GENOMICS is a trademark filed by Complete Genomics, Inc. on June 8, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Complete Genomics, Inc. (19 trademarks)

2071 Stierlin Court
Mountain View, CA 94043

Entity Type: 03

Trademark Details

Filing Date

June 8, 2023

Registration Date

Not Registered

Published for Opposition

June 4, 2024

Goods & Services

Biological tissue cultures for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic reagents for medical purposes; drug testing kits comprising primarily medical diagnostic reagents and assays for testing body fluids; preparations for detecting genetic predispositions for medical purposes; reagents for use in medical genetic testing. Enzyme preparations for medical purposes; Bacterial preparations for medical and veterinary use; Chemical pharmaceutical preparations for detecting genetic predispositions; Chemical reagents for medical or veterinary purposes

Biochemical catalysts; reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields. Protein in raw material form for scientific and medical research; Chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Chemical reagents, other than for medical or veterinary purposes; Biological preparations, other than for medical or veterinary purposes, namely, for use in industry and science; Bacterial preparations, other than for medical and veterinary use; Biochemical preparations for scientific purposes; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes

Medical apparatus and instruments for detecting tumor cancer and genetic diseases; diagnostic testing apparatus for testing samples of body fluid, tissue and organ for medical use; diagnostic apparatus for the detection of cancer; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical apparatus and instruments for detecting and treating tumor and cancer; nucleic acid purification reagent kits comprised primarily of probes, buffers, and reagents for medical purposes; genome machine for medical purposes, namely, genetic sequencer for medical diagnostic purposes.

Analyzers for genome information, namely, laboratory devices for detecting genetic sequences, and recorded computer programs for scientific analysis of genetic sequences; nucleic acid sequencer for scientific purposes; gene amplification instrument for scientific purposes; laboratory apparatus, namely, protein sequence analysis equipment; DNA chips; diagnostic apparatus for the detection of pathogens for laboratory or research use; Recorded computer programs for biological data mining; Recorded computer programs for developing bioinformatics database for others; data processing apparatus; bio-chips for research or scientific purposes

Filing History

TEAS STATEMENT OF USE RECEIVED
Apr 13, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 29, 2026 EX3G
SOU EXTENSION 3 FILED
Jan 28, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 28, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 23, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 23, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 23, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 31, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 31, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 31, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 30, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 30, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 30, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 30, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 30, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 30, 2024 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 23, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 26, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2024 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Mar 5, 2024 GPRN
PRIORITY ACTION E-MAILED
Mar 5, 2024 GPRA
PRIORITY ACTION WRITTEN
Mar 5, 2024 CPRA
ASSIGNED TO EXAMINER
Feb 29, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 13, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2023 NWOS
NEW APPLICATION ENTERED
Jun 12, 2023 NWAP